Gyre Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.

About GYRE

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). 

CEO
Han Ying
CEOHan Ying
Employees
5
Employees5
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1997
Founded1997
Employees
5
Employees5

GYRE Key Statistics

Market cap
865.24M
Market cap865.24M
Price-Earnings ratio
192.52
Price-Earnings ratio192.52
Dividend yield
—
Dividend yield—
Average volume
103.61K
Average volume103.61K
High today
$9.63
High today$9.63
Low today
$9.23
Low today$9.23
Open price
$9.33
Open price$9.33
Volume
132.02K
Volume132.02K
52 Week high
$19.00
52 Week high$19.00
52 Week low
$6.11
52 Week low$6.11

People also own

Based on the portfolios of people who own GYRE. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
SNDL
NIO
Plug Power
Aurora Cannabis
Lucid Group
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.